SYNAPSE RESEARCH MANAGEMENT PARTNERS SL - Spain 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:600-700
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:800-900
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:500-600
Networking Rank (Reputation):300-400
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2014-01-01 - 2024-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 18
As coordinator: 1
As participant: 17
Sole participant: 0
Coordinator / Participant Ratio: 0.06*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 96.531.225 2.705.109 2
2019 1.199.125 35.645.725 2.314.887 1 3
2018 0 18.604.681 1.343.970 2
2017 0 71.697.938 5.282.325 5
2016 0 15.998.136 746.500 2
2015 0 3.463.481 275.250 1
2014 0 7.492.000 540.952 2
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
JANSSEN PHARMACEUTICA NV12
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM8
NOVARTIS PHARMA8
NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE7
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD7
ELI LILLY AND COMPANY LIMITED6
PFIZER LIMITED6
F HOFFMANNLA ROCHE5
SANOFIAVENTIS5
ALZHEIMER EUROPE4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN4
THE UNIVERSITY OF EDINBURGH4
UNIVERSITY OF NEWCASTLE UPON TYNE4
ABBVIE INC3
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS3
ASTRAZENECA AB3
BAYER3
CELGENE MANAGEMENT SARL3
EUROPEAN MOLECULAR BIOLOGY LABORATORY3
FORUM DES PATIENTS EUROPEENS3
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS3
OSPEDALE PEDIATRICO BAMBINO GESU3
STICHTING VUMC3
TAKEDA DEVELOPMENT CENTRE EUROPE3
THE UNIVERSITY OF LIVERPOOL3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF HELSINKI3
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS2
ASTRAZENECA2
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG2
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE2
CERTARA UK LIMITED2
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION2
EUROPEAN HEMATOLOGY ASSOCIATION2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL2
EUROPEAN RESEARCH INITIATIVE ON CLL EV2
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION2
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS2
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS2
FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM2
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON2
FUNDACIO PRIVADA INSTITUT DE RECERCA DE L'HOSPITAL DE LA SANTA CREU I SANT PAU2
FUNDACION HOSPITAL LA FE2
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON2
GE HEALTHCARE LIMITED2
GENOME RESEARCH2
GLAXOSMITHKLINE BIOLOGICALS2
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT2
GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT NON PROFIT ORGANISATION2
GMV SOLUCIONES GLOBALES INTERNET SAU2
GPOH GEMEINNUTZIGE2
GROUPE FRANCOPHONE DES MYELODYSPLASIES2
H LUNDBECK AS2
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER2
IXICO TECHNOLOGIES LIMITED2
KLINIKUM DER UNIVERSITAET ZU KOELN2
LEUKANET EV2
MASARYKOVA UNIVERZITA2
MEDISAPIENS OY2
MEDIZINISCHE UNIVERSITAET WIEN2
MENARINI RICERCHE2
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN2
MERCK SHARP & DOHME CORP2
MLL MUNCHNER LEUKAMIELABOR2
NOVO NORDISK2
SANOFI PASTEUR2
SERVICIO MADRILENO DE SALUD2
ST GEORGE'S HOSPITAL MEDICAL SCHOOL2
STIFTUNG ELN FOUNDATION2
TARTU ULIKOOL2
TEAM IT RESEARCH SL2
THE LYMPHOMA STUDY ASSOCIATION2
UCB BIOPHARMA2
UNIVERSIDAD DE NAVARRA2
UNIVERSITA DEGLI STUDI DI TORINO2
UNIVERSITAET BERN2
UNIVERSITAET ULM2
UNIVERSITAT WIEN2
UNIVERSITEIT LEIDEN2
UNIVERSITY OF BOLOGNA2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF YORK2
VIB VZW2
ABBOTT BIOLOGICALS BV1
ABBVIE DEUTSCHLAND GMBH & CO KG1
ABX CRO ADVANCED PHARMACEUTICAL SERVICES FORSCHUNGSGESELLSCHAFT MBH1
AC IMMUNE1
ACADEMISCH ZIEKENHUIS GRONINGEN1
ACADEMISCH ZIEKENHUIS LEIDEN1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AGENZIA ITALIANA DEL FARMACO1
ALEXION SERVICES EUROPE SPRL1
ALLERGAN LIMITED1
AMGEN1
AMGEN LIMITED1
ARISTOTLE UNIVERSITY OF THESSALONIKI1
ASSOCIATION INTERNATIONALE DE STANDARDISATION BIOLOGIQUE POUR L'EUROPE1
AVERBIS1
BARTS AND THE LONDON NHS TRUST1

Constancy:

Total number of partners: 407
Partner loyalty:
Frequent Partner: (> 2 projects): 126
Rare Partner: 281
Frequent / Rare Partner Ratio: 0.45

Project overview:

Start dateProjectacronymrolefundingpartners
2020-10-01HEALTHCARE ALLIANCE FOR RESOURCEFUL MEDICINES OFFENSIVE AGAINST NEOPLASMS IN HEMATOLOGY – PLUS HARMONY PLUSparticipant6.715.62541
2020-01-01EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS ERA4TBparticipant89.815.60033
2019-11-01EU Patient- cEntric clinicAl tRial pLatform EU-PEARLparticipant12.004.95337
2019-03-01Efficiently Networking European Neurodegeneration Research NEURONETcoordinator1.199.12510
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99829
2019-01-01Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe HTxparticipant9.640.77515
2018-11-01European Health Data and Evidence Network EHDENparticipant14.105.75022
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93135
2017-09-01Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management eTRANSAFEparticipant20.000.00027
2017-07-01Development of Robust and Innovative Vaccine Effectiveness DRIVEparticipant8.999.81315
2017-01-01REspiratory Syncytial virus Consortium in EUrope - Sofia ref.: 116019 RESCEUparticipant14.498.12518
2017-01-01Translational quantitative systems toxicology to improve the understanding of the safety of medicines - Sofia: 116030 TransQSTparticipant8.000.00023
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2016-11-01Real world Outcomes across the AD spectrum for better care: Multimodal data Access Platform - Sofia ref.: 116020 ROADMAPparticipant3.998.25026
2016-10-01Amyloid imaging to Prevent Alzheimer’s Disease – Sofia ref.: 115952 AMYPADparticipant11.999.88615
2015-05-01Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities (MedBioinformatics) MedBioinformaticsparticipant3.463.4819
2014-02-01Treatment of late onset bacterial sepsis caused by vancomycin susceptible bacteria in neonates and infants aged under three months NEOVANCparticipant5.993.00012
2014-01-01Semantic Data Platform for Healthcare SEMCAREparticipant1.499.0005